Medicare Group QSC

Medicare Group QSC

QQSE:MCGS
4.81
QAR
-0.03
(-0.68%)
0.30EPS
18.74P/E
1.59BMarket Cap
Oct 27Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.48
1.88
2.12
1.67
1.67
1.72
1.74
1.69
1.72
1.73
1.73
1.86
1.79
1.77
Basic EPS, GAAP
0.32
0.64
0.64
0.23
0.28
0.3
0.28
0.3
0.28
0.28
0.23
0.21
0.27
0.3
Free Cash Flow per Basic Share
0.29
0.36
-0.04
0.51
0.45
0.4
0.24
0.22
0.14
0.2
0.09
0.19
0.12
0.35
Dividend per Share
0.18
0.29
0.48
0.5
0.29
0.39
0.29
0.28
0.28
0.24
0.26
0.22
0.2
0.2
Book Value per Share
2.87
3.29
3.89
3.61
3.56
3.62
3.63
3.65
3.66
3.7
3.6
3.59
3.66
3.61
Tangible Book Value per Share
2.87
3.29
3.89
3.61
3.56
3.62
3.63
3.65
3.66
3.7
3.6
3.59
3.66
3.61
Basic Weighted Avg Shares
281
281
281
281
281
281
281
281
281
281
281
281
281
281
Sales/Revenue/Turnover
418
528
596
469
471
484
491
477
484
487
486
523
503
497
Operating Margin (%)
22.1
33.99
30.25
18.84
14.99
15.76
14.86
16.65
16.03
15.35
14.17
16.01
12.72
8.09
Depreciation Expense
28
22
25
26
28
31
27
27
28
28
28
27
26
19
Net Income, GAAP
89
182
180
65
80
85
78
86
79
79
66
60
76
85
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
21.42
34.35
30.27
13.89
17
17.45
15.94
17.93
16.35
16.25
13.52
11.47
15.12
17.04
Working Capital
207
316
278
172
119
99
65
52
41
46
11
95
53
14
LT Debt
- -
- -
53
34
20
16
83
85
99
95
101
151
121
107
Total Equity
809
926
1,096
1,017
1,002
1,018
1,021
1,028
1,030
1,040
1,012
1,009
1,031
1,017
Return on Invested Capital (%)
9.75
19.41
16.69
5.32
7.51
7.98
7.27
7.66
7.29
6.69
5.98
7.17
5.38
6.75
Return on Capital (%)
11.25
20.92
17.37
6.06
7.75
8.21
7.58
7.91
7.21
7.02
5.85
5.14
6.4
7.2
Return on Common Equity (%)
11.36
20.92
17.84
6.17
7.93
8.37
7.67
8.35
7.68
7.65
6.4
5.94
7.45
8.29

Capital Structure

QAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
29
- -
29
LT Borrowings
121
- -
107
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
281
281
281
Market Capitalization
1,866
1,431
1,592

Working Capital

QAR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
206
212
169
Cash, Cash Equivalents & STI
64
73
47
Accounts Receivable, Net
166
- -
68
Inventories
27
30
29
Total Current Liabilities
153
171
155
Payables & Accruals
- -
- -
- -
ST Debt
29
- -
29
Deferred Revenue
- -
- -
- -

Growth Rates

QAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-0.57%
0.06%
2.16%
Free Cash Flow
-148.17%
8.14%
-35.15%
Net Income, GAAP
-4%
-1.29%
26.57%
Sales/Revenue/Turnover
-1.39%
1.13%
-3.99%
Total Cash Common Dividend
-6.58%
-6.33%
-10.27%

Quarterly Revenue

QAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
130
129
124
141
523
2025
128
130
- -
126
503
2026
111
129
- -
- -
- -

Quarterly Earnings Per Share

QAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
-0.03
0.09
0.09
0.21
2025
0.08
0.07
- -
0.05
0.27
2026
0.04
0.15
- -
- -
- -

Quarterly Dividends Per Share

QAR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.22
- -
- -
0.22
2025
- -
0.2
- -
- -
0.2
2026
- -
- -
- -
- -
- -

Company Description

CEO
Khaled Mohammed Asad Al-Emadi
Full Time Employees
610
Sector
Health services
Industry
Hospital/Nursing management
Address
Al Ahli Hospital Building Doha DA Qatar 6401
IPO Date
Dec 21, 1999
Business
Medicare Group Q.P.S.C. (MCGS.QA) operates as a Qatar-based healthcare provider specializing in hospital and clinic services. The company owns and manages Al-Ahli Hospital in Doha, offering clinical departments including anesthesiology, chiropractics, dental care, dermatology, emergency services, gastroenterology, general surgery, heart care, internal medicine, obstetrics and gynecology, ophthalmology, orthopedics and traumatology, pediatrics, psychiatry, pulmonary and chest medicine, and urology; ancillary services encompass dietary services, pathology and laboratory medicine, pharmacy, physical and rehabilitative medicine, radiology, speech and language therapy, neonatal intensive care, intensive care, and coronary care units. It also provides outpatient clinics, home nursing through Re'aya, physical therapy via Enaya, and healthy nutrition services through Hema (Haya), with operations focused exclusively in Qatar. Founded in 1996 and headquartered at Al Ahli Hospital Building, Ahmed bin Ali Street, Wadi Al Sail, Doha, the company, formerly known as Al Ahli Specialized Hospital Company Q.S.C., lists on the Qatar Stock Exchange's main market in the consumer goods and services sector. Recent developments include a blanket agreement for medical referrals with Hamad Medical Corporation in July 2025, closure of Al-Wakrah Clinics and Urgent Care Unit in April 2024 as part of restructuring, net profit growth of 9.3% in Q1 2025 and achievement of QR60 million net profits for 2024 with a recommended 19.80% cash dividend, board member replacement in 2024, and ongoing investments in property and equipment exceeding QR54 million in 2024.